Merck and Samsung BioLogics to Extend Strategic Alliance
02-Nov-2017 -
Merck announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
The alliance would accelerate process development and clinical material production at small biotech start-ups ...
biologics
biopharmaceutical production
biopharmaceuticals
+2